드러그인포 약품요약정보 - 뉴트리닐피디-4액 2000mL(백)

허가정보

항목

내용

청구코드(KD코드)
비급여점검코드
상한금액

646600830[E04270071] [보험코드에 따른 약품기본정보 직접조회]
\0 원/2000mL/백(2022.11.01)(현재약가)
\14,737 원/2000mL/백(2017.02.01)(변경전약가)
[상병코드조회]
[질병코드조회]

빠른조회


요약정보	[효능] [용법] [금기] [신중투여] [이상반응]

상세정보	[효능] [용법] [경고] [금기] [신중투여] [이상반응] [일반주의] [상호작용] [임산부] [수유부] [소아] [고령자] [신장애환자] [간장애환자] [적용주의] [과량투여] [임상검사치] [보관] [기타]

제품성상

연한 노란색의 폴리염화비닐 플라스틱 용기에 든 연한 노란색의 투명한 복막 투석액 [제형정보 확인]

포장·유통단위

2000mL/백

포장·코드단위

약품규격	단위	포장형태	대표코드	표준코드	비고
2리터	1 개	백	8806466008305	8806466008312

주성분코드

324000BIS [동일한 주성분코드를 가진 오리지날 또는 제네릭 의약품 조회]

허가사항 원문조회

[허가사항 원문조회]

효능효과

[적응증 별 검색]

복막투석으로 유지되고 있는 영양실조상태의 신부전환자(35g/liter 미만의 알부민농도)에 대한 영양학적 보충

용법용량

* 절대 임의복용하지 마시고 반드시 의사 또는 약사와 상담하시기 바랍니다.

[처방약어]
복강 내 투여용으로만 사용하여야 하며, 정맥용이 아니다.
이 약은 일회 투여용 제품이다.
이 약은 환자에게 적절한 속도로 투여하며, 투여량 조절은 의사의 처방에 따른다.
치료 형태, 치료 빈도, 양의 변경, 투석액 저류 시간은 처방한 의사의 감독에 따른다.
담당 의사는 환자의 증세에 따라 치료 방식, 처치횟수, 교환 용량, 투석 시간 및 기간을 조절해야 한다.
권장 식이단백 섭취량은 투석 받는 성인의 경우 약 1.2 g/kg 이상이다.
뉴트리닐 1.1% 아미노산 2 Liter Bag은 70kg 성인에 대해 0.30g/kg/day에 해당하는 22g의 아미노산을 제공한다.
<준비방법>
오버파우치채로 투석액을 체온까지 덥힌 후 사용한다.
복강 내 투여 시 환자의 카테터와 액의 용기를 연결하는 데에는 특별한 카테터와 적절한 투여 세트를 사용하여야 한다.

[BMI지수 계산] [Body Surface Area 계산] [Cockcroft-Gault GFR 계산] [MDRD GFR 계산]

금기

1) 최근 복부수술 환자 및 위장장해 환자(치료의 잇점과 가능한 합병증을 고려해야 한다.)

2) 혈청 요소치 38mmol/L(2.4g/L) 이상환자

3) 요독증, 저칼륨혈증환자(이 약은 칼륨을 함유하고 있지 않다.)

4) 제품의 아미노산 혹은 첨가제에 대한 과민반응이 있는 환자

5) 대사성 산증이 있는 환자

6) 선천적 아미노대사증이 있는 환자

7) 간장애가 있는 환자

8) 심근경색 및 그 병력이 있는 환자

9) 복막투석의 효과를 저해하거나 감염의 위험을 증가시키는 교정되지 않은 구조적 결함이 있는 환자

10) 복막기능 상실을 경험한 자 또는 복막기능을 저하하는 광범위한 유착이 있는 환자

신중투여

1) 회복되지 않은 산성혈증, 중증의 간장애, 고암모니아혈증, 하나 혹은 몇가지 아미노산에 대한 과민성이 있는 경우는 주의를 요한다.

대사성산증은 이 약의 치료 이전과 이 약의 치료 중에 보정해야 한다.

2) 복막의 파열과 횡격막 수술, 선천성 기형이나 외상이 치유 될 때까지의 상태, 복부의 종양, 복막의 감염, 탈장, 분루, 결장루, 큰 다낭성 신장, 또는 복막, 복부표면, 내부 복강 등을 포함하는 복부의 다른 질환이 있는 경우

3) 대동맥 그래프트 배치술 및 중증 폐질환 등의 경우

4) 강심배당체를 처방받는 환자(칼륨, 칼슘, 마그네슘의 혈중 농도를 주의깊게 관찰하여야 함.)

이상반응

1) 다음과 같이 복막투석에 따른 이상반응이 나타날 수 있다.

: 복강감염, 전해질 및 체액의 불균형, 대사성 산성혈증, 과질소혈증, 팽창 및 포만감, 횡경막 상승으로 인한 호흡곤란, 고혈압 또는 저혈압, 설사, 변비

2) 임상시험에 의하면 아래와 같은 이상반응이 환자의 5%이상에게서 관찰되었다. 대조군과 비교하여 2%이상 높은 이상반응의 발생률을 기재하였다.

임상 시험 이상 반응
기관분류 (System Organ Class)	이상반응	빈도	이상반응발현률 (%환자)
감염	카테터 부위 감염 감염	흔하게 흔하게	8.9 5.1
혈액과 림프 이상	빈혈	흔하게	6.3
대사 및 영양 이상	산증 체액량과다 저칼륨혈증 체액량감소	매우 흔하게 매우 흔하게 흔하게 흔하게	35.4 13.9 8.9 6.3
정신적 이상	우울	흔하게	5.1
호흡, 흉부, 종격동 이상	호흡곤란	흔하게	6.3
소화계 이상	오심/구토 식욕부진 오심 위염	매우 흔하게 매우 흔하게 매우 흔하게 흔하게	19.0 15.2 15.2 5.1
전신 및 투여부위 이상	무력증	매우 흔하게	10.1
검사	혈액요소 증가	매우 흔하게	15.2
* 빈도는 다음과 같은 기준을 기반으로 한다. (매우 흔하게(≥1/10), 흔하게(≥1/100-<1/10), 흔하지않게(≥1/1,000-<1/100), 드물게(≥1/10,000-<1/1,000), 매우 드물게(<1/10,000)) * 오심과 구토의 부분은 MedRA 11.0에서 나타나있지 않으나, 근거 자료의 내용을 반영하기 위해 기재하였다.

3) 다음과 같은 이상반응이 시판 후 보고되었다.

이러한 반응은 MedDRA System Organ Class (SOC)을 이용하여 중대성 순으로 나열하였다.

- 감염: 세균성 복막염

- 면역계 이상: 과민반응

- 대사 및 영양 이상: 식욕부진

- 소화계 이상: 복통, 복막염, 복막액의 혼탁, 유출, 복부 불쾌감

- 피부 및 피하 질환: 혈관부종, 소양증

- 전신 및 투여부위 이상: 카테터 부위 합병증, 발열, 권태감

- 검사 : 복막액 분석 이상

4) 국내에서 6년 동안 602명을 대상으로 실시한 시판 후 조사 결과 추가로 나타난 이상반응 중 약과의 인과관계를 배제할 수 없는 이상반응은 다음과 같다. : 식욕부진, 구토, 오심, 소화불량, 복통

5)국내 시판 후 수집된 중대한 이상사례 분석•평가 결과 확인된 이상사례는 다음과 같다. 다만, 이로써 곧 해당성분과 다음의 이상사례 간에 인과관계가 입증된 것을 의미하는 것은 아니다.
• 감염 : 폐렴

[주요 이상반응정보]

상호작용

1) 이 약의 상호작용에 대한 연구는 없었으며, 투석 진행중에 약제의 혈중농도가 감소할 수 있다.

2) 약물용량은 일정하게 해야 한다.

3) 디기탈리스 처치를 받고 있는 환자에서는 칼륨혈증을 모니터해야 한다.

4) 당뇨병 환자들은 인슐린 용량 또는 저혈당요법시에 혈당수치의 신중한 모니터링이 요구된다. 또한 인슐린의 용량 또는 기타 고혈당의 처방을 조절해야 한다.

환자들은 인슐린 용량 또는 저혈당요법시에 신중한 모니터링이 요구된다.

Off-label Usage

[조회]

Related FDA Approved Drug

기준 성분:GLYCINE
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER (GLYCINE)
GLYCINE 1.5% IN PLASTIC CONTAINER (GLYCINE)
기준 성분:CALCIUM CHLORIDE
ACETATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE)
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE)
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE)
AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE)
BALANCED SALT (CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE)
BSS (CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE)
BSS PLUS (CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE)
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER (CALCIUM CHLORIDE)
CARDIOPLEGIC IN PLASTIC CONTAINER (CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER (AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
ELLIOTTS B SOLUTION (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE)
ENDOSOL EXTRA (CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE)
INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE)
INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE)
INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE)
ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE)
ISOLYTE E IN PLASTIC CONTAINER (CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE)
ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE)
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)
LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
NAVSTEL (CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE)
PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE)
PLASMA-LYTE R IN PLASTIC CONTAINER (CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE)
PLEGISOL IN PLASTIC CONTAINER (CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 2/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 4/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BK 0/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
TPN ELECTROLYTES IN PLASTIC CONTAINER (CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)

정보요약

드럭인포 의약품 요약/상세정보

코드 및 분류정보

항목	내용
성분코드	M088656/글리신 0.510그램 / M099297/엘트레오닌 0.646그램 / M040439/염화칼슘 0.184그램 / M050800/엘세린 0.510그램 / M040670/엘트립토판 0.270그램 / M050373/염산리신(염산엘리신) 0.955그램 / M051111/염화마그네슘 0.051그램 / M040698/엘페닐알라닌 0.570그램 / M100637/엘메치오닌 0.850그램 / M100995/엘로이신 1.020그램 / M051013/엘알라닌 0.951그램 / M051752/엘프롤린 0.595그램 / M100994/엘발린 1.393그램 / M051999/엘히스티딘 0.714그램 / M051654/엘티로신 0.300그램 / M040426/염화나트륨 5.380그램 / M100996/엘이소로이신 0.850그램 / M051322/젖산나트륨 4.480그램 / M051011/엘알기닌 1.071그램 /
주성분코드	324000BIS [동일한 주성분코드를 가진 오리지날 또는 제네릭 의약품 조회]
대표코드	8806466008305
BIT 약효분류	관류액 및 투석액(Perfusate, Dialysate)
ATC 코드	Hypertonic solutions / B05DB [코드분류상세설명] [ATC코드예측]
복지부분류코드	341 (인공신장관류용제 )
의약품 바코드정보	내용보기 뉴트리닐피디-4액/E04270071 제품규격:2리터/제품수량:1/제형:개 폼목기준코드:199704446 /대표코드:8806466008305/표준코드:8806466008312 구바코드:-/비고:백
주성분코드 분석 및 중복처방 검토	[주성분코드 분석 및 중복처방 검토]
Drugs By Indication	[전체보기]
Drugs By Classification	[전체보기]

제품정보

항목	내용
청구코드(KD코드) 비급여점검코드 상한금액	646600830[E04270071] [보험코드에 따른 약품기본정보 직접조회] \0 원/2000mL/백(2022.11.01)(최신약가) \14,737 원/2000mL/백(2017.02.01)(변경전약가) [상병코드조회] [질병코드집 다운로드]
제품성상	연한 노란색의 폴리염화비닐 플라스틱 용기에 든 연한 노란색의 투명한 복막 투석액 [제형정보 확인]
포장·유통단위	2000mL/백
보관방법	30℃ 이하에서 차광보관
동일주성분코드 검색순위	유료정보입니다.

복약정보

항목

내용

LACTmed 바로가기

[바로가기]

약리작용

유료정보입니다.

복약지도

유료정보입니다.

임부에대한투여

*	전체임신 기간별로 여러등급이 존재할 수 있으며 가장 위험도가 높은 정보만 보여집니다. 단, 복합제의 경우 모든 복합제성분에 대한 임부투여등급이 표시된것은 절대 아니며 표시된것중에 가장 위험도가 높은 정보만 나타납니다.

FDA : C등급

*	상기 임부투여에 대한 정보는 전산처리 되면서 입력 오류 가능성이 존재합니다. 오류 가능성을 최소화하기 위하여 많은 노력을 기울이고 있으나, 그 정확성에 대하여 확신을 드릴 수 없습니다. 이에 대해 회사는 책임을 지지 않습니다.
*	반드시 공신력 있는 문헌을 다시 한번 참고 하시기 바라며 의사 또는 약사의 판단에 따라 투여여부가 결정되어야 합니다.

Pharmacokinetics

유료정보입니다.

복약라벨

이미지

복약설명

변비가 생길수 있습니다.

*	복약이미지는 모든 복약지도 사항을 표시한것은 아니며, 추가적으로 업데이트되거나 수정될 수 있습니다.
*	복약이미지의 표시여부는 실제 약물복용시 중요도에 따른것은 아니며 단순히 허가정보상 키워드를 기준으로 등록되었습니다.
*	귀하가 복약이미지 정보를 신뢰함은 전적으로 귀하의 책임입니다. 드럭인포는 이에 대한 어떠한 보증도 하지 않습니다.

보관상 주의

조제시 주의

심사정보

항목	내용
DUR 관련 고시	[병용연령금기 의약품 / 임부금기 의약품 / 비용효과적 함량 의약품 / 안전성 관련 급여중지 의약품]

학술정보

항목	내용
DUR (의약품사용평가)	병용금기 : 고시된 병용금기 내용은 없습니다. [상호작용/병용금기검색] 연령대금기 : 고시된 연령금기 내용은 없습니다. [연령대금기상세검색]
독성정보	Calcium에 대한 독성정보 : 정보보기 출처: 국립독성과학원 독성물질정보DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do
Mechanism of Action	Calcium에 대한 Mechanism_Of_Action 정보 Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. More than 500 human proteins are known to bind or transport calcium. The skeleton acts as a major mineral storage site for the element and releases Ca2+ ions into the bloodstream under controlled conditions. Circulating calcium is either in the free, ionized form or bound to blood proteins such as serum albumin. Parathyroid hormone (secreted from the parathyroid gland) regulates the resorption of Ca2+ from bone. Calcitonin stimulates incorporation of calcium in bone, although this process is largely independent of calcitonin. Although calcium flow to and from the bone is neutral, about 5 mmol is turned over a day. Bone serves as an important storage point for calcium, as it contains 99% of the total body calcium. Low calcium intake may also be a risk factor in the development of osteoporosis. The best-absorbed form of calcium from a pill is a calcium salt like carbonate or phosphate. Calcium gluconate and calcium lactate are absorbed well by pregnant women. Seniors absorb calcium lactate, gluconate and citrate better unless they take their calcium supplement with a full breakfast. The currently recommended calcium intake is 1,500 milligrams per day for women not taking estrogen and 800 milligrams per day for women on estrogen. There is close to 300 milligrams of calcium in one cup of fluid milk. Calcium carbonate is currently the best and least expensive form of calcium supplement available. Glycine에 대한 Mechanism_Of_Action 정보 In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS. L-alanine에 대한 Mechanism_Of_Action 정보 L-Alanine is a non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system. BCAAs are used as a source of energy for muscle cells. During prolonged exercise, BCAAs are released from skeletal muscles and their carbon backbones are used as fuel, while their nitrogen portion is used to form another amino acid, Alanine. Alanine is then converted to Glucose by the liver. This form of energy production is called the Alanine-Glucose cycle, and it plays a major role in maintaining the body's blood sugar balance. L-arginine에 대한 Mechanism_Of_Action 정보 Many of supplemental L-arginine's activities, including its possible anti-atherogenic actions, may be accounted for by its role as the precursor to nitric oxide or NO. NO is produced by all tissues of the body and plays very important roles in the cardiovascular system, immune system and nervous system. NO is formed from L-arginine via the enzyme nitric oxide synthase or synthetase (NOS), and the effects of NO are mainly mediated by 3,'5' -cyclic guanylate or cyclic GMP. NO activates the enzyme guanylate cyclase, which catalyzes the synthesis of cyclic GMP from guanosine triphosphate or GTP. Cyclic GMP is converted to guanylic acid via the enzyme cyclic GMP phosphodiesterase. NOS is a heme-containing enzyme with some sequences similar to cytochrome P-450 reductase. Several isoforms of NOS exist, two of which are constitutive and one of which is inducible by immunological stimuli. The constitutive NOS found in the vascular endothelium is designated eNOS and that present in the brain, spinal cord and peripheral nervous system is designated nNOS. The form of NOS induced by immunological or inflammatory stimuli is known as iNOS. iNOS may be expressed constitutively in select tissues such as lung epithelium. All the nitric oxide synthases use NADPH (reduced nicotinamide adenine dinucleotide phosphate) and oxygen (O2) as cosubstrates, as well as the cofactors FAD (flavin adenine dinucleotide), FMN (flavin mononucleotide), tetrahydrobiopterin and heme. Interestingly, ascorbic acid appears to enhance NOS activity by increasing intracellular tetrahydrobiopterin. eNOS and nNOS synthesize NO in response to an increased concentration of calcium ions or in some cases in response to calcium-independent stimuli, such as shear stress. In vitro studies of NOS indicate that the Km of the enzyme for L-arginine is in the micromolar range. The concentration of L-arginine in endothelial cells, as well as in other cells, and in plasma is in the millimolar range. What this means is that, under physiological conditions, NOS is saturated with its L-arginine substrate. In other words, L-arginine would not be expected to be rate-limiting for the enzyme, and it would not appear that supraphysiological levels of L-arginine which could occur with oral supplementation of the amino acid^would make any difference with regard to NO production. The reaction would appear to have reached its maximum level. However, in vivo studies have demonstrated that, under certain conditions, e.g. hypercholesterolemia, supplemental L-arginine could enhance endothelial-dependent vasodilation and NO production. L-histidine에 대한 Mechanism_Of_Action 정보 Since the actions of supplemental L-histidine are unclear, any postulated mechanism is entirely speculative. However, some facts are known about L-histidine and some of its metabolites, such as histamine and trans-urocanic acid, which suggest that supplemental L-histidine may one day be shown to have immunomodulatory and/or antioxidant activities. Low free histidine has been found in the serum of some rheumatoid arthritis patients. Serum concentrations of other amino acids have been found to be normal in these patients. L-histidine is an excellent chelating agent for such metals as copper, iron and zinc. Copper and iron participate in a reaction (Fenton reaction) that generates potent reactive oxygen species that could be destructive to tissues, including joints. L-histidine is the obligate precursor of histamine, which is produced via the decarboxylation of the amino acid. In experimental animals, tissue histamine levels increase as the amount of dietary L-histidine increases. It is likely that this would be the case in humans as well. Histamine is known to possess immunomodulatory and antioxidant activity. Suppressor T cells have H2 receptors, and histamine activates them. Promotion of suppressor T cell activity could be beneficial in rheumatoid arthritis. Further, histamine has been shown to down-regulate the production of reactive oxygen species in phagocytic cells, such as monocytes, by binding to the H2 receptors on these cells. Decreased reactive oxygen species production by phagocytes could play antioxidant, anti-inflammatory and immunomodulatory roles in such diseases as rheumatoid arthritis. This latter mechanism is the rationale for the use of histamine itself in several clinical trials studying histamine for the treatment of certain types of cancer and viral diseases. In these trials, down-regulation by histamine of reactive oxygen species formation appears to inhibit the suppression of natural killer (NK) cells and cytotoxic T lymphocytes, allowing these cells to be more effective in attacking cancer cells and virally infected cells. L-isoleucine에 대한 Mechanism_Of_Action 정보 (Applies to Valine, Leucine and Isoleucine) This group of essential amino acids are identified as the branched-chain amino acids, BCAAs. Because this arrangement of carbon atoms cannot be made by humans, these amino acids are an essential element in the diet. The catabolism of all three compounds initiates in muscle and yields NADH and FADH2 which can be utilized for ATP generation. The catabolism of all three of these amino acids uses the same enzymes in the first two steps. The first step in each case is a transamination using a single BCAA aminotransferase, with a-ketoglutarate as amine acceptor. As a result, three different a-keto acids are produced and are oxidized using a common branched-chain a-keto acid dehydrogenase, yielding the three different CoA derivatives. Subsequently the metabolic pathways diverge, producing many intermediates. The principal product from valine is propionylCoA, the glucogenic precursor of succinyl-CoA. Isoleucine catabolism terminates with production of acetylCoA and propionylCoA; thus isoleucine is both glucogenic and ketogenic. Leucine gives rise to acetylCoA and acetoacetylCoA, and is thus classified as strictly ketogenic. There are a number of genetic diseases associated with faulty catabolism of the BCAAs. The most common defect is in the branched-chain a-keto acid dehydrogenase. Since there is only one dehydrogenase enzyme for all three amino acids, all three a-keto acids accumulate and are excreted in the urine. The disease is known as Maple syrup urine disease because of the characteristic odor of the urine in afflicted individuals. Mental retardation in these cases is extensive. Unfortunately, since these are essential amino acids, they cannot be heavily restricted in the diet; ultimately, the life of afflicted individuals is short and development is abnormal The main neurological problems are due to poor formation of myelin in the CNS. L-leucine에 대한 Mechanism_Of_Action 정보 This group of essential amino acids are identified as the branched-chain amino acids, BCAAs. Because this arrangement of carbon atoms cannot be made by humans, these amino acids are an essential element in the diet. The catabolism of all three compounds initiates in muscle and yields NADH and FADH2 which can be utilized for ATP generation. The catabolism of all three of these amino acids uses the same enzymes in the first two steps. The first step in each case is a transamination using a single BCAA aminotransferase, with a-ketoglutarate as amine acceptor. As a result, three different a-keto acids are produced and are oxidized using a common branched-chain a-keto acid dehydrogenase, yielding the three different CoA derivatives. Subsequently the metabolic pathways diverge, producing many intermediates. The principal product from valine is propionylCoA, the glucogenic precursor of succinyl-CoA. Isoleucine catabolism terminates with production of acetylCoA and propionylCoA; thus isoleucine is both glucogenic and ketogenic. Leucine gives rise to acetylCoA and acetoacetylCoA, and is thus classified as strictly ketogenic. There are a number of genetic diseases associated with faulty catabolism of the BCAAs. The most common defect is in the branched-chain a-keto acid dehydrogenase. Since there is only one dehydrogenase enzyme for all three amino acids, all three a-keto acids accumulate and are excreted in the urine. The disease is known as Maple syrup urine disease because of the characteristic odor of the urine in afflicted individuals. Mental retardation in these cases is extensive. Unfortunately, since these are essential amino acids, they cannot be heavily restricted in the diet; ultimately, the life of afflicted individuals is short and development is abnormal The main neurological problems are due to poor formation of myelin in the CNS. L-lysine에 대한 Mechanism_Of_Action 정보 Proteins of the herpes simplex virus are rich in L-arginine, and tissue culture studies indicate an enhancing effect on viral replication when the amino acid ratio of L-arginine to L-lysine is high in the tissue culture media. When the ratio of L-lysine to L-arginine is high, viral replication and the cytopathogenicity of herpes simplex virus have been found to be inhibited. L-lysine may facilitate the absorption of calcium from the small intestine. L-methionine에 대한 Mechanism_Of_Action 정보 The mechanism of the possible anti-hepatotoxic activity of L-methionine is not entirely clear. It is thought that metabolism of high doses of acetaminophen in the liver lead to decreased levels of hepatic glutathione and increased oxidative stress. L-methionine is a precursor to L-cysteine. L-cysteine itself may have antioxidant activity. L-cysteine is also a precursor to the antioxidant glutathione. Antioxidant activity of L-methionine and metabolites of L-methionine appear to account for its possible anti-hepatotoxic activity. Recent research suggests that methionine itself has free-radical scavenging activity by virtue of its sulfur, as well as its chelating ability. L-phenylalanine에 대한 Mechanism_Of_Action 정보 The mechanism of L-phenylalanine's putative antidepressant activity may be accounted for by its precursor role in the synthesis of the neurotransmitters norepinephrine and dopamine. Elevated brain norepinephrine and dopamine levels are thought to be associated with antidepressant effects. The mechanism of L-phenylalanine's possible antivitiligo activity is not well understood. It is thought that L-phenylalanine may stimulate the production of melanin in the affected skin L-proline에 대한 Mechanism_Of_Action 정보 Glycogenic, by L-Proline oxidase in the kidney, it is ring-opened and is oxidized to form L-Glutamic acid. L-Ornithine and L-Glutamic acid are converted to L-Proline via L-Glutamic acid-gamma-semialdehyde. It is contained abundantly in collagen, and is intimately involved in the function of arthrosis and chordae. L-serine에 대한 Mechanism_Of_Action 정보 L-Serine plays a role in cell growth and development (cellular proliferation). The conversion of L-serine to glycine by serine hydroxymethyltransferase results in the formation of the one-carbon units necessary for the synthesis of the purine bases, adenine and guanine. These bases when linked to the phosphate ester of pentose sugars are essential components of DNA and RNA and the end products of energy producing metabolic pathways, ATP and GTP. In addition, L-serine conversion to glycine via this same enzyme provides the one-carbon units necessary for production of the pyrimidine nucleotide, deoxythymidine monophosphate, also an essential component of DNA. L-threonine에 대한 Mechanism_Of_Action 정보 L-Threonine is a precursor to the amino acids glycine and serine. It acts as a lipotropic in controlling fat build-up in the liver. May help combat mental illness and may be very useful in indigestion and intestinal malfunctions. Also, threonine prevents excessive liver fat. Nutrients are more readily absorbed when threonine is present. L-tryptophan에 대한 Mechanism_Of_Action 정보 A number of important side reactions occur during the catabolism of tryptophan on the pathway to acetoacetate. The first enzyme of the catabolic pathway is an iron porphyrin oxygenase that opens the indole ring. The latter enzyme is highly inducible, its concentration rising almost 10-fold on a diet high in tryptophan. Kynurenine is the first key branch point intermediate in the pathway. Kynurenine undergoes deamniation in a standard transamination reaction yielding kynurenic acid. Kynurenic acid and metabolites have been shown to act as antiexcitotoxics and anticonvulsives. A second side branch reaction produces anthranilic acid plus alanine. Another equivalent of alanine is produced further along the main catabolic pathway, and it is the production of these alanine residues that allows tryptophan to be classified among the glucogenic and ketogenic amino acids. The second important branch point converts kynurenine into 2-amino-3-carboxymuconic semialdehyde, which has two fates. The main flow of carbon elements from this intermediate is to glutarate. An important side reaction in liver is a transamination and several rearrangements to produce limited amounts of nicotinic acid, which leads to production of a small amount of NAD⁺ and NADP⁺.
Pharmacology	Glycine에 대한 Pharmacology 정보 Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system. L-alanine에 대한 Pharmacology 정보 Is an important source of energy for muscle tissue, the brain and central nervous system; strengthens the immune system by producing antibodies; helps in the metabolism of sugars and organic acids. L-arginine에 대한 Pharmacology 정보 Studies have shown that is has improved immune responses to bacteria, viruses and tumor cells; promotes wound healing and regeneration of the liver; causes the release of growth hormones; considered crucial for optimal muscle growth and tissue repair. L-histidine에 대한 Pharmacology 정보 Is found abundantly in hemoglobin; has been used in the treatment of rheumatoid arthritis, allergic diseases, ulcers and anemia. A deficiency can cause poor hearing. L-isoleucine에 대한 Pharmacology 정보 They provide ingredients for the manufacturing of other essential biochemical components in the body, some of which are utilized for the production of energy, stimulants to the upper brain and helping you to be more alert. L-leucine에 대한 Pharmacology 정보 An essential amino acid. (Claim) Leucine helps with the regulation of blood-sugar levels, the growth and repair of muscle tissue (such as bones, skin and muscles), growth hormone production, wound healing as well as energy regulation. It can assist to prevent the breakdown of muscle proteins that sometimes occur after trauma or severe stress. It may also be beneficial for individuals with phenylketonuria - a condition in which the body cannot metabolize the amino acid phenylalanine L-lysine에 대한 Pharmacology 정보 Insures the adequate absorption of calcium; helps form collagen ( which makes up bone cartilage & connective tissues); aids in the production of antibodies, hormones & enzymes. Recent studies have shown that Lysine may be effective against herpes by improving the balance of nutrients that reduce viral growth. A deficiency may result in tiredness, inability to concentrate, irritability, bloodshot eyes, retarded growth, hair loss, anemia & reproductive problems. L-methionine에 대한 Pharmacology 정보 L-Methionine is a principle supplier of sulfur which prevents disorders of the hair, skin and nails; helps lower cholesterol levels by increasing the liver's production of lecithin; reduces liver fat and protects the kidneys; a natural chelating agent for heavy metals; regulates the formation of ammonia and creates ammonia-free urine which reduces bladder irritation; influences hair follicles and promotes hair growth. L-methionine may protect against the toxic effects of hepatotoxins, such as acetaminophen. Methionine may have antioxidant activity. L-phenylalanine에 대한 Pharmacology 정보 Used by the brain to produce Norepinephrine, a chemical that transmits signals between nerve cells and the brain; keeps you awake and alert; reduces hunger pains; functions as an antidepressant and helps improve memory. L-proline에 대한 Pharmacology 정보 L-Proline is a major amino acid found in cartilage and is important for maintaining youthful skin as well as repair of muscle, connective tissue and skin damage. It is also essential for the immune system, and for necessary balance of this formula. It is an essential component of collagen and is important for proper functioning of joints and tendons. L-Proline is extremely important for the proper functioning of joints and tendons. Helps maintain and strengthen heart muscles. L-serine에 대한 Pharmacology 정보 Serine is classified as a nutritionally non-essential amino acid. Serine is critical for the production of the body's proteins, enzymes and muscle tissue. Serine is needed for the proper metabolism of fats and fatty acids. It also helps in the production of antibodies. Serine is used as a natural moisturizing agent in some cosmetics and skin care products. The main source of essential amino acids is from the diet, non-essential amino acids are normally synthesize by humans and other mammals from common intermediates. L-threonine에 대한 Pharmacology 정보 L-Threonine is an essential amino acid that helps to maintain the proper protein balance in the body. It is important for the formation of collagen, elastin, and tooth enamel, and aids liver and lipotropic function when combined with aspartic acid and methionine. L-tryptophan에 대한 Pharmacology 정보 Tryptophan is critical for the production of the body's proteins, enzymes and muscle tissue. It is also essential for the production of niacin, the synthesis of the neurotransmitter serotonin and melatonin. Tryptophan supplements can be used as natural relaxants to help relieve insomnia. Tryptophan can also reduce anxiety and depression and has been shown to reduce the intensity of migraine headaches. Other promising indications include the relief of chronic pain, reduction of impulsivity or mania and the treatment of obsessive or compulsive disorders. Tryptophan also appears to help the immune system and can reduce the risk of cardiac spasms. Tryptophan deficiencies may lead to coronary artery spasms. Tryptophan is used as an essential nutrient in infant formulas and intravenous feeding. Tryptophan is marketed as a prescription drug (Tryptan) for those who do not seem to respond well to conventional antidepressants. It may also be used to treat those afflicted with seasonal affective disorder (a winter-onset depression). Tryptopan serves as the precursor for the synthesis of serotonin (5-hydroxytryptamine, 5-HT) and melatonin (N-acetyl-5-methoxytryptamine).
Metabolism	L-histidine에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Not Available L-isoleucine에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Not Available L-lysine에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Not Available L-methionine에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Glutamine SynthetaseMethylenetetrahydrofolate reductase L-proline에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Proline oxidase L-tryptophan에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Tryptophan 2,3-dioxygenaseAromatic-L-amino-acid decarboxylase (AADC)
Absorption	Glycine에 대한 Absorption 정보 Absorbed from the small intestine via an active transport mechanism. L-arginine에 대한 Absorption 정보 Absorbed from the lumen of the small intestine into the enterocytes. Absorption is efficient and occurs by an active transport mechanism. L-histidine에 대한 Absorption 정보 Absorbed from the small intestine via an active transport mechanism requiring the presence of sodium. L-isoleucine에 대한 Absorption 정보 Absorbed from the small intestine by a sodium-dependent active-transport process L-lysine에 대한 Absorption 정보 Absorbed from the lumen of the small intestine into the enterocytes by an active transport process L-methionine에 대한 Absorption 정보 Absorbed from the lumen of the small intestine into the enterocytes by an active transport process. L-phenylalanine에 대한 Absorption 정보 Absorbed from the small intestine by a sodium dependent active transport process.
Pharmacokinetics	Aminoacetic Acid(Glycine)의 약물동력학자료 대사 : Glycine은 단백, creatinine, glycocholic acid, glutathione, uric acid, heme 등의 합성에 관여한다. 체내에서의 분해는 여러단계로 이루어지며 주된 경로는 가역적인 산화적 분해이다. Serine이 정상적인 분해산물이다. 혈장 반감기 : 85분 Calcium Chloride의 약물동력학자료 흡수 : 정맥 칼슘염은 직접 혈류로 유입된다. 분포 : 태반통과 유즙분비 Sodium Chloride의 약물동력학자료 분포 : 전신으로 분포 소실 : 주로 뇨배설, 땀, 눈물, 타액으로도 분비됨 Magnesium Chloride의 약물동력학자료 흡수 : 복용량의 ⅓-½이 소장에서 서서히 흡수된다. 단백결합 : 약 25-30% 소실 : 흡수된 양의 90% 이상이 신배설된다. L-methionine의 약물동력학자료 대사 : S-adenosylmethionine을 거쳐 homocysteine으로 전환된다. 그 후 80%가 cystathione, cysteine, taurine, inorganic sulphate로 점차로 대사된다. L-arginine의 약물동력학자료 최고 혈중농도 도달 : 경구 : 2시간 최대 효과 발현 : 당뇨 진단 : 정맥주사 : 20-45 분 혈당의 최고 상승은 20분 후에 나타나며, 인슐린의 최대 상승은 20-30 분 후에 나타나며 glucagon은 30-45 분 후에 나타난다. 성장호르몬 보유 진단 : 정맥주사 : 1-2 시간 Arginine 30 g을 30분간 정맥주사 후 성장호르몬의 최대 상승이 약 1-2 시간 후에 나타난다. 작용 지속 시간 : 정맥주사 : 1시간 흡수 : 위장관에서 잘 흡수됨 대사 : 간에서 arginase에 의해 guanidino group이 가수분해되어 urea와 ornithine을 생성한다. Ornithine은 궁극적으로 glucose 생성에 이용된다. 소실 : 신장 : 사구체로 여과되고 신세뇨관으로 재흡수된다. 반감기 : 1.2-2 시간
Biotransformation	Glycine에 대한 Biotransformation 정보 Hepatic L-arginine에 대한 Biotransformation 정보 Some metabolism of L-arginine takes place in the enterocytes. L-arginine not metabolized in the enterocytes enters the portal circulation from whence it is transported to the liver, where again some portion of the amino acid is metabolized. L-isoleucine에 대한 Biotransformation 정보 Hepatic L-lysine에 대한 Biotransformation 정보 Hepatic L-methionine에 대한 Biotransformation 정보 Hepatic L-phenylalanine에 대한 Biotransformation 정보 Hepatic. L-phenylalanine that is not metabolized in the liver is distributed via the systemic circulation to the various tissues of the body, where it undergoes metabolic reactions similar to those that take place in the liver. L-proline에 대한 Biotransformation 정보 Hepatic L-threonine에 대한 Biotransformation 정보 Hepatic L-tryptophan에 대한 Biotransformation 정보 Hepatic.
Toxicity	Glycine에 대한 Toxicity 정보 ORL-RAT LD₅₀ 7930 mg/kg, SCU-RAT LD₅₀ 5200 mg/kg, IVN-RAT LD₅₀ 2600 mg/kg, ORL-MUS LD₅₀ 4920 mg/kg; Doses of 1 gram daily are very well tolerated. Mild gastrointestinal symptoms are infrequently noted. In one study doses of 90 grams daily were also well tole. L-arginine에 대한 Toxicity 정보 Oral supplementation with L-arginine at doses up to 15 grams daily are generally well tolerated. The most common adverse reactions of higher doses from 15 to 30 grams daily are nausea, abdominal cramps and diarrhea. Some may experience these symptoms at lower doses. L-histidine에 대한 Toxicity 정보 ORL-RAT LD₅₀ > 15000 mg/kg, IPR-RAT LD₅₀ > 8000 mg/kg, ORL-MUS LD₅₀ > 15000 mg/kg, IVN-MUS LD₅₀ > 2000 mg/kg; Mild gastrointestinal side effects. L-isoleucine에 대한 Toxicity 정보 Symptoms of hypoglycemia, increased mortality in ALS patients taking large doses of BCAAs L-lysine에 대한 Toxicity 정보 Not Available L-methionine에 대한 Toxicity 정보 Doses of L-methionine of up to 250 mg daily are generally well tolerated. Higher doses may cause nausea, vomiting and headache. Healthy adults taking 8 grams of L-methionine daily for four days were found to have reduced serum folate levels and leucocytosis. Healthy adults taking 13.9 grams of L-methionine daily for five days were found to have changes in serum pH and potassium and increased urinary calcium excretion. Schizophrenic patients given 10 to 20 grams of L-methionine daily for two weeks developed functional psychoses. Single doses of 8 grams precipitated encephalopathy in patients with cirrhosis. L-phenylalanine에 대한 Toxicity 정보 L-phenylalanine will exacerbate symptoms of phenylketonuria if used by phenylketonurics. L-phenylalanine was reported to exacerbate tardive dyskinesia when used by some with schizophrenia. L-proline에 대한 Toxicity 정보 Not Available L-tryptophan에 대한 Toxicity 정보 Oral rat LD₅₀: > 16 gm/kg. Investigated as a tumorigen, mutagen, reproductive effector. Symptoms of overdose include agitation, confusion, diarrhea, fever, overactive reflexes, poor coordination, restlessness, shivering, sweating, talking or acting with excitement you cannot control, trembling or shaking, twitching, and vomiting.
Drug Interactions	Calcium에 대한 Drug_Interactions 정보 Alendronate Formation of non-absorbable complexesAmprenavir The antiacid decreases the absorption of amprenavirAtazanavir This gastric pH modifier decreases the levels/effects of atazanavirChloroquine The antiacid decreases the absorption of chloroquineCiprofloxacin Formation of non-absorbable complexesDapsone Formation of non-absorbable complexesDelavirdine The antiacid decreases the effect of delavirdineDemeclocycline Formation of non-absorbable complexesDoxycycline Formation of non-absorbable complexesEnoxacin Formation of non-absorbable complexesFosamprenavir The antiacid decreases the absorption of amprenavirGrepafloxacin Formation of non-absorbable complexesIbandronate Formation of non-absorbable complexesIndinavir The antiacid decreases the absorption of indinavirItraconazole The antacid decreases the effect of the imidazoleKetoconazole The antacid decreases the effect of the imidazoleLevofloxacin Formation of non-absorbable complexesLevothyroxine Calcium decreases absorption of levothyroxineLomefloxacin Formation of non-absorbable complexesMethacycline Formation of non-absorbable complexesMinocycline Formation of non-absorbable complexesMoxifloxacin Formation of non-absorbable complexesNorfloxacin Formation of non-absorbable complexesOfloxacin Formation of non-absorbable complexesOxytetracycline Formation of non-absorbable complexesPefloxacin Formation of non-absorbable complexesPolystyrene sulfonate Formation of non-absorbable complexesRisedronate Formation of non-absorbable complexesTetracycline Formation of non-absorbable complexesTrovafloxacin Formation of non-absorbable complexesClodronate Formation of non-absorbable complexesEtidronic acid Formation of non-absorbable complexesMycophenolate mofetil Formation of non-absorbable complexesTemafloxacin Formation of non-absorbable complexes Glycine에 대한 Drug_Interactions 정보 Not Available L-arginine에 대한 Drug_Interactions 정보 Not Available L-histidine에 대한 Drug_Interactions 정보 Not Available L-isoleucine에 대한 Drug_Interactions 정보 Not Available L-lysine에 대한 Drug_Interactions 정보 Not Available L-methionine에 대한 Drug_Interactions 정보 Not Available L-phenylalanine에 대한 Drug_Interactions 정보 Not Available L-proline에 대한 Drug_Interactions 정보 Not Available L-tryptophan에 대한 Drug_Interactions 정보 Not Available
CYP450 Drug Interaction	[CYP450 Table직접조회]
Food Interaction	L-methionine에 대한 Food Interaction 정보 Take with food.
Drug Target	[Drug Target]
Description	Calcium에 대한 Description 정보 Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. The skeleton acts as a major mineral storage site for the element and releases Ca2+ ions into the bloodstream under controlled conditions. Circulating calcium is either in the free, ionized form or bound to blood proteins such as serum albumin. Although calcium flow to and from the bone is neutral, about 5 mmol is turned over a day. Bone serves as an important storage point for calcium, as it contains 99% of the total body calcium. Low calcium intake may also be a risk factor in the development of osteoporosis. The best-absorbed form of calcium from a pill is a calcium salt like carbonate or phosphate. Calcium gluconate and calcium lactate are absorbed well by pregnant women. Seniors absorb calcium lactate, gluconate and citrate better unless they take their calcium supplement with a full breakfast. Glycine에 대한 Description 정보 A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [PubChem] L-alanine에 대한 Description 정보 A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system. [PubChem] L-arginine에 대한 Description 정보 An essential amino acid that is physiologically active in the L-form. [PubChem] L-histidine에 대한 Description 정보 An essential amino acid that is required for the production of histamine. [PubChem] L-isoleucine에 대한 Description 정보 An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels. [PubChem] L-leucine에 대한 Description 정보 An essential branched-chain amino acid important for hemoglobin formation. [PubChem] L-lysine에 대한 Description 정보 L-Lysine (abbreviated as Lys or K)[1] is an 慣-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. This amino acid is an essential amino acid, which means that humans cannot synthesize it. Its codons are AAA and AAG.L-Lysine is a base, as are arginine and histidine. The 琯-amino group often participates in hydrogen bonding and as a general base in catalysis. Common posttranslational modifications include methylation of the 琯-amino group, giving methyl-, dimethyl-, and trimethyllysine. The latter occurs in calmodulin. Other posttranslational modifications include acetylation. Collagen contains hydroxylysine which is derived from lysine by lysyl hydroxylase. O-Glycosylation of lysine residues in the endoplasmic reticulum or Golgi apparatus is used to mark certain proteins for secretion from the cell. L-methionine에 대한 Description 정보 A sulfur containing essential amino acid that is important in many body functions. It is a chelating agent for heavy metals. [PubChem] L-phenylalanine에 대한 Description 정보 An essential aromatic amino acid that is a precursor of melanin; dopamine; noradrenalin (norepinephrine), and thyroxine. [PubChem] L-proline에 대한 Description 정보 A non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons. [PubChem] L-serine에 대한 Description 정보 A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids. [PubChem] L-threonine에 대한 Description 정보 An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins. [PubChem] L-tryptophan에 대한 Description 정보 An essential amino acid that is necessary for normal growth in infants and for nitrogen balance in adults. It is a precursor of indole alkaloids in plants. It is a precursor of serotonin (hence its use as an antidepressant and sleep aid). It can be a precursor to niacin, albeit inefficiently, in mammals. [PubChem]
Drug Category	Glycine에 대한 Drug_Category 정보 Dietary supplementGlycine AgentsMicronutrientNon-Essential Amino Acids L-alanine에 대한 Drug_Category 정보 Dietary supplementMicronutrientNon-Essential Amino Acids L-arginine에 대한 Drug_Category 정보 Conditionally Essential Amino AcidsDietary supplementMicronutrient L-histidine에 대한 Drug_Category 정보 Conditionally Essential Amino AcidsDietary supplementMicronutrient L-isoleucine에 대한 Drug_Category 정보 Dietary supplementEssential Amino AcidsMicronutrient L-leucine에 대한 Drug_Category 정보 Dietary supplementEssential Amino AcidsMicronutrient L-lysine에 대한 Drug_Category 정보 Dietary supplementEssential Amino AcidsMicronutrient L-methionine에 대한 Drug_Category 정보 Dietary supplementEssential Amino AcidsMicronutrient L-phenylalanine에 대한 Drug_Category 정보 Dietary supplementEssential Amino AcidsMicronutrient L-proline에 대한 Drug_Category 정보 Dietary supplementMicronutrientNon-Essential Amino Acids L-serine에 대한 Drug_Category 정보 Dietary supplementMicronutrientNon-Essential Amino Acids L-threonine에 대한 Drug_Category 정보 Dietary supplementEssential Amino AcidsMicronutrient L-tryptophan에 대한 Drug_Category 정보 Antidepressive Agents, Second-GenerationDietary supplementEssential Amino AcidsMicronutrient
Smiles String Canonical	Calcium에 대한 Smiles_String_canonical 정보 Not Available Glycine에 대한 Smiles_String_canonical 정보 NCC(O)=O L-alanine에 대한 Smiles_String_canonical 정보 CC(N)C(O)=O L-arginine에 대한 Smiles_String_canonical 정보 NC(CCCN=C(N)N)C(O)=O L-histidine에 대한 Smiles_String_canonical 정보 NC(CC1=CN=CN1)C(O)=O L-isoleucine에 대한 Smiles_String_canonical 정보 CCC(C)C(N)C(O)=O L-leucine에 대한 Smiles_String_canonical 정보 CC(C)CC(N)C(O)=O L-lysine에 대한 Smiles_String_canonical 정보 NCCCCC(N)C(O)=O L-methionine에 대한 Smiles_String_canonical 정보 CSCCC(N)C(O)=O L-phenylalanine에 대한 Smiles_String_canonical 정보 NC(CC1=CC=CC=C1)C(O)=O L-proline에 대한 Smiles_String_canonical 정보 OC(=O)C1CCCN1 L-serine에 대한 Smiles_String_canonical 정보 NC(CO)C(O)=O L-threonine에 대한 Smiles_String_canonical 정보 CC(O)C(N)C(O)=O L-tryptophan에 대한 Smiles_String_canonical 정보 NC(CC1=CNC2=CC=CC=C12)C(O)=O
Smiles String Isomeric	Calcium에 대한 Smiles_String_isomeric 정보 Not Available Glycine에 대한 Smiles_String_isomeric 정보 NCC(O)=O L-alanine에 대한 Smiles_String_isomeric 정보 C[C@H](N)C(O)=O L-arginine에 대한 Smiles_String_isomeric 정보 N[C@@H](CCC\N=C(\N)N)C(O)=O L-histidine에 대한 Smiles_String_isomeric 정보 N[C@@H](CC1=CN=CN1)C(O)=O L-isoleucine에 대한 Smiles_String_isomeric 정보 CC[C@H](C)[C@H](N)C(O)=O L-leucine에 대한 Smiles_String_isomeric 정보 CC(C)C[C@@H](N)C(O)=O L-lysine에 대한 Smiles_String_isomeric 정보 NCCCC[C@H](N)C(O)=O L-methionine에 대한 Smiles_String_isomeric 정보 CSCC[C@H](N)C(O)=O L-phenylalanine에 대한 Smiles_String_isomeric 정보 N[C@@H](CC1=CC=CC=C1)C(O)=O L-proline에 대한 Smiles_String_isomeric 정보 OC(=O)[C@@H]1CCCN1 L-serine에 대한 Smiles_String_isomeric 정보 N[C@@H](CO)C(O)=O L-threonine에 대한 Smiles_String_isomeric 정보 C[C@@H](O)[C@H](N)C(O)=O L-tryptophan에 대한 Smiles_String_isomeric 정보 N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O
InChI Identifier	Calcium에 대한 InChI_Identifier 정보 Not Available Glycine에 대한 InChI_Identifier 정보 InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)/f/h4H L-alanine에 대한 InChI_Identifier 정보 InChI=1/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1/f/h5H L-arginine에 대한 InChI_Identifier 정보 InChI=1/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1/f/h11H,8-9H2 L-histidine에 대한 InChI_Identifier 정보 InChI=1/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1/f/h9-10H L-isoleucine에 대한 InChI_Identifier 정보 InChI=1/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1/f/h8H L-leucine에 대한 InChI_Identifier 정보 InChI=1/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/f/h8H L-lysine에 대한 InChI_Identifier 정보 InChI=1/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1/f/h9H L-methionine에 대한 InChI_Identifier 정보 InChI=1/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1/f/h7H L-phenylalanine에 대한 InChI_Identifier 정보 InChI=1/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1/f/h11H L-proline에 대한 InChI_Identifier 정보 InChI=1/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1/f/h7H L-serine에 대한 InChI_Identifier 정보 InChI=1/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1/f/h6H L-threonine에 대한 InChI_Identifier 정보 InChI=1/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1/f/h7H L-tryptophan에 대한 InChI_Identifier 정보 InChI=1/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1/f/h14H
Chemical IUPAC Name	Calcium에 대한 Chemical_IUPAC_Name 정보 Not Available Glycine에 대한 Chemical_IUPAC_Name 정보 2-aminoacetic acid L-alanine에 대한 Chemical_IUPAC_Name 정보 (2S)-2-aminopropanoic acid L-arginine에 대한 Chemical_IUPAC_Name 정보 (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid L-histidine에 대한 Chemical_IUPAC_Name 정보 (2S)-2-amino-3-(3H-imidazol-4-yl)propanoic acid L-isoleucine에 대한 Chemical_IUPAC_Name 정보 (2S,3S)-2-amino-3-methylpentanoic acid L-leucine에 대한 Chemical_IUPAC_Name 정보 2-amino-4-methylpentanoic acid L-lysine에 대한 Chemical_IUPAC_Name 정보 (2S)-2,6-diaminohexanoic acid L-methionine에 대한 Chemical_IUPAC_Name 정보 (2S)-2-amino-4-methylsulfanylbutanoic acid L-phenylalanine에 대한 Chemical_IUPAC_Name 정보 (2S)-2-amino-3-phenylpropanoic acid L-proline에 대한 Chemical_IUPAC_Name 정보 (2S)-pyrrolidine-2-carboxylic acid L-serine에 대한 Chemical_IUPAC_Name 정보 (2S)-2-amino-3-hydroxypropanoic acid L-threonine에 대한 Chemical_IUPAC_Name 정보 (2S,3R)-2-amino-3-hydroxybutanoic acid L-tryptophan에 대한 Chemical_IUPAC_Name 정보 (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid
Drug-Induced Toxicity Related Proteins	LYSINE 의 Drug-Induced Toxicity Related Protein정보 Replated Protein:Tamm-Horsfall protein Drug:Lysine Toxicity:persisting acute renal failure . [바로가기] METHIONINE 의 Drug-Induced Toxicity Related Protein정보 Replated Protein:NMDA receptor-regulated protein Drug:methionine Toxicity:cerebrovascular disease. [바로가기] Replated Protein:Cystathionine beta-synthase Drug:methionine Toxicity:lipoprotein peroxidation and platelet aggregation. [바로가기] Replated Protein:Methylenetetrahydrofolate reductase Drug:methionine Toxicity:lipoprotein peroxidation and platelet aggregation. [바로가기]

사용자컨텐츠

항목

내용

핵심 요약 정보